Pharma & Healthcare
Global COPD Therapeutics Market Insights, Forecast to 2030
- Mar 11, 25
- ID: 4137
- Pages: 73
- Figures: 103
- Views: 17
Chronic Obstructive Pulmonary Disease (COPD) is a progressive disorder associated with chronic inflammation of the airways and lungs. Persistent breathing difficulties and repeated exacerbations of COPD symptoms make the disease one of the leading causes of morbidity, and the fifth-leading cause of death in the world.
Market Analysis and Insights: Global COPD Therapeutics Market
The global COPD Therapeutics market is projected to grow from US$ 599 million in 2024 to US$ 849.7 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.0% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for COPD Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of COPD Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for COPD Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the COPD Therapeutics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global COPD Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for COPD Therapeutics revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
GlaxoSmithKline
AstraZeneca
Theravance Biopharma
Mylan
Segment by Type
Bronchodilators
Inhaled Corticosteroids
Other
Segment by Application
Adult
Child
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of COPD Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of COPD Therapeutics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, COPD Therapeutics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Market Analysis and Insights: Global COPD Therapeutics Market
The global COPD Therapeutics market is projected to grow from US$ 599 million in 2024 to US$ 849.7 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.0% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for COPD Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of COPD Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for COPD Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the COPD Therapeutics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global COPD Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for COPD Therapeutics revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
GlaxoSmithKline
AstraZeneca
Theravance Biopharma
Mylan
Segment by Type
Bronchodilators
Inhaled Corticosteroids
Other
Segment by Application
Adult
Child
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of COPD Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of COPD Therapeutics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, COPD Therapeutics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global COPD Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Bronchodilators
1.2.3 Inhaled Corticosteroids
1.2.4 Other
1.3 Market by Application
1.3.1 Global COPD Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Adult
1.3.3 Child
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global COPD Therapeutics Market Perspective (2019-2030)
2.2 Global COPD Therapeutics Growth Trends by Region
2.2.1 COPD Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 COPD Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 COPD Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 COPD Therapeutics Market Dynamics
2.3.1 COPD Therapeutics Industry Trends
2.3.2 COPD Therapeutics Market Drivers
2.3.3 COPD Therapeutics Market Challenges
2.3.4 COPD Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue COPD Therapeutics by Players
3.1.1 Global COPD Therapeutics Revenue by Players (2019-2024)
3.1.2 Global COPD Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global COPD Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of COPD Therapeutics, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global COPD Therapeutics Market Concentration Ratio
3.4.1 Global COPD Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by COPD Therapeutics Revenue in 2023
3.5 Global Key Players of COPD Therapeutics Head office and Area Served
3.6 Global Key Players of COPD Therapeutics, Product and Application
3.7 Global Key Players of COPD Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 COPD Therapeutics Breakdown Data by Type
4.1 Global COPD Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global COPD Therapeutics Forecasted Market Size by Type (2025-2030)
5 COPD Therapeutics Breakdown Data by Application
5.1 Global COPD Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global COPD Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America COPD Therapeutics Market Size (2019-2030)
6.2 North America COPD Therapeutics Market Size by Type
6.2.1 North America COPD Therapeutics Market Size by Type (2019-2024)
6.2.2 North America COPD Therapeutics Market Size by Type (2025-2030)
6.2.3 North America COPD Therapeutics Market Share by Type (2019-2030)
6.3 North America COPD Therapeutics Market Size by Application
6.3.1 North America COPD Therapeutics Market Size by Application (2019-2024)
6.3.2 North America COPD Therapeutics Market Size by Application (2025-2030)
6.3.3 North America COPD Therapeutics Market Share by Application (2019-2030)
6.4 North America COPD Therapeutics Market Size by Country
6.4.1 North America COPD Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America COPD Therapeutics Market Size by Country (2019-2024)
6.4.3 North America COPD Therapeutics Market Size by Country (2025-2030)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe COPD Therapeutics Market Size (2019-2030)
7.2 Europe COPD Therapeutics Market Size by Type
7.2.1 Europe COPD Therapeutics Market Size by Type (2019-2024)
7.2.2 Europe COPD Therapeutics Market Size by Type (2025-2030)
7.2.3 Europe COPD Therapeutics Market Share by Type (2019-2030)
7.3 Europe COPD Therapeutics Market Size by Application
7.3.1 Europe COPD Therapeutics Market Size by Application (2019-2024)
7.3.2 Europe COPD Therapeutics Market Size by Application (2025-2030)
7.3.3 Europe COPD Therapeutics Market Share by Application (2019-2030)
7.4 Europe COPD Therapeutics Market Size by Country
7.4.1 Europe COPD Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe COPD Therapeutics Market Size by Country (2019-2024)
7.4.3 Europe COPD Therapeutics Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China COPD Therapeutics Market Size (2019-2030)
8.2 China COPD Therapeutics Market Size by Type
8.2.1 China COPD Therapeutics Market Size by Type (2019-2024)
8.2.2 China COPD Therapeutics Market Size by Type (2025-2030)
8.2.3 China COPD Therapeutics Market Share by Type (2019-2030)
8.3 China COPD Therapeutics Market Size by Application
8.3.1 China COPD Therapeutics Market Size by Application (2019-2024)
8.3.2 China COPD Therapeutics Market Size by Application (2025-2030)
8.3.3 China COPD Therapeutics Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia COPD Therapeutics Market Size (2019-2030)
9.2 Asia COPD Therapeutics Market Size by Type
9.2.1 Asia COPD Therapeutics Market Size by Type (2019-2024)
9.2.2 Asia COPD Therapeutics Market Size by Type (2025-2030)
9.2.3 Asia COPD Therapeutics Market Share by Type (2019-2030)
9.3 Asia COPD Therapeutics Market Size by Application
9.3.1 Asia COPD Therapeutics Market Size by Application (2019-2024)
9.3.2 Asia COPD Therapeutics Market Size by Application (2025-2030)
9.3.3 Asia COPD Therapeutics Market Share by Application (2019-2030)
9.4 Asia COPD Therapeutics Market Size by Region
9.4.1 Asia COPD Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia COPD Therapeutics Market Size by Region (2019-2024)
9.4.3 Asia COPD Therapeutics Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America COPD Therapeutics Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America COPD Therapeutics Market Size by Type
10.2.1 Middle East, Africa, and Latin America COPD Therapeutics Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America COPD Therapeutics Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America COPD Therapeutics Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America COPD Therapeutics Market Size by Application
10.3.1 Middle East, Africa, and Latin America COPD Therapeutics Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America COPD Therapeutics Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America COPD Therapeutics Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America COPD Therapeutics Market Size by Country
10.4.1 Middle East, Africa, and Latin America COPD Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America COPD Therapeutics Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America COPD Therapeutics Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline COPD Therapeutics Introduction
11.1.4 GlaxoSmithKline Revenue in COPD Therapeutics Business (2019-2024)
11.1.5 GlaxoSmithKline Recent Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca COPD Therapeutics Introduction
11.2.4 AstraZeneca Revenue in COPD Therapeutics Business (2019-2024)
11.2.5 AstraZeneca Recent Developments
11.3 Theravance Biopharma
11.3.1 Theravance Biopharma Company Details
11.3.2 Theravance Biopharma Business Overview
11.3.3 Theravance Biopharma COPD Therapeutics Introduction
11.3.4 Theravance Biopharma Revenue in COPD Therapeutics Business (2019-2024)
11.3.5 Theravance Biopharma Recent Developments
11.4 Mylan
11.4.1 Mylan Company Details
11.4.2 Mylan Business Overview
11.4.3 Mylan COPD Therapeutics Introduction
11.4.4 Mylan Revenue in COPD Therapeutics Business (2019-2024)
11.4.5 Mylan Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global COPD Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Bronchodilators
1.2.3 Inhaled Corticosteroids
1.2.4 Other
1.3 Market by Application
1.3.1 Global COPD Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Adult
1.3.3 Child
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global COPD Therapeutics Market Perspective (2019-2030)
2.2 Global COPD Therapeutics Growth Trends by Region
2.2.1 COPD Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 COPD Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 COPD Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 COPD Therapeutics Market Dynamics
2.3.1 COPD Therapeutics Industry Trends
2.3.2 COPD Therapeutics Market Drivers
2.3.3 COPD Therapeutics Market Challenges
2.3.4 COPD Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue COPD Therapeutics by Players
3.1.1 Global COPD Therapeutics Revenue by Players (2019-2024)
3.1.2 Global COPD Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global COPD Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of COPD Therapeutics, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global COPD Therapeutics Market Concentration Ratio
3.4.1 Global COPD Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by COPD Therapeutics Revenue in 2023
3.5 Global Key Players of COPD Therapeutics Head office and Area Served
3.6 Global Key Players of COPD Therapeutics, Product and Application
3.7 Global Key Players of COPD Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 COPD Therapeutics Breakdown Data by Type
4.1 Global COPD Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global COPD Therapeutics Forecasted Market Size by Type (2025-2030)
5 COPD Therapeutics Breakdown Data by Application
5.1 Global COPD Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global COPD Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America COPD Therapeutics Market Size (2019-2030)
6.2 North America COPD Therapeutics Market Size by Type
6.2.1 North America COPD Therapeutics Market Size by Type (2019-2024)
6.2.2 North America COPD Therapeutics Market Size by Type (2025-2030)
6.2.3 North America COPD Therapeutics Market Share by Type (2019-2030)
6.3 North America COPD Therapeutics Market Size by Application
6.3.1 North America COPD Therapeutics Market Size by Application (2019-2024)
6.3.2 North America COPD Therapeutics Market Size by Application (2025-2030)
6.3.3 North America COPD Therapeutics Market Share by Application (2019-2030)
6.4 North America COPD Therapeutics Market Size by Country
6.4.1 North America COPD Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America COPD Therapeutics Market Size by Country (2019-2024)
6.4.3 North America COPD Therapeutics Market Size by Country (2025-2030)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe COPD Therapeutics Market Size (2019-2030)
7.2 Europe COPD Therapeutics Market Size by Type
7.2.1 Europe COPD Therapeutics Market Size by Type (2019-2024)
7.2.2 Europe COPD Therapeutics Market Size by Type (2025-2030)
7.2.3 Europe COPD Therapeutics Market Share by Type (2019-2030)
7.3 Europe COPD Therapeutics Market Size by Application
7.3.1 Europe COPD Therapeutics Market Size by Application (2019-2024)
7.3.2 Europe COPD Therapeutics Market Size by Application (2025-2030)
7.3.3 Europe COPD Therapeutics Market Share by Application (2019-2030)
7.4 Europe COPD Therapeutics Market Size by Country
7.4.1 Europe COPD Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe COPD Therapeutics Market Size by Country (2019-2024)
7.4.3 Europe COPD Therapeutics Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China COPD Therapeutics Market Size (2019-2030)
8.2 China COPD Therapeutics Market Size by Type
8.2.1 China COPD Therapeutics Market Size by Type (2019-2024)
8.2.2 China COPD Therapeutics Market Size by Type (2025-2030)
8.2.3 China COPD Therapeutics Market Share by Type (2019-2030)
8.3 China COPD Therapeutics Market Size by Application
8.3.1 China COPD Therapeutics Market Size by Application (2019-2024)
8.3.2 China COPD Therapeutics Market Size by Application (2025-2030)
8.3.3 China COPD Therapeutics Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia COPD Therapeutics Market Size (2019-2030)
9.2 Asia COPD Therapeutics Market Size by Type
9.2.1 Asia COPD Therapeutics Market Size by Type (2019-2024)
9.2.2 Asia COPD Therapeutics Market Size by Type (2025-2030)
9.2.3 Asia COPD Therapeutics Market Share by Type (2019-2030)
9.3 Asia COPD Therapeutics Market Size by Application
9.3.1 Asia COPD Therapeutics Market Size by Application (2019-2024)
9.3.2 Asia COPD Therapeutics Market Size by Application (2025-2030)
9.3.3 Asia COPD Therapeutics Market Share by Application (2019-2030)
9.4 Asia COPD Therapeutics Market Size by Region
9.4.1 Asia COPD Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia COPD Therapeutics Market Size by Region (2019-2024)
9.4.3 Asia COPD Therapeutics Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America COPD Therapeutics Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America COPD Therapeutics Market Size by Type
10.2.1 Middle East, Africa, and Latin America COPD Therapeutics Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America COPD Therapeutics Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America COPD Therapeutics Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America COPD Therapeutics Market Size by Application
10.3.1 Middle East, Africa, and Latin America COPD Therapeutics Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America COPD Therapeutics Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America COPD Therapeutics Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America COPD Therapeutics Market Size by Country
10.4.1 Middle East, Africa, and Latin America COPD Therapeutics Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America COPD Therapeutics Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America COPD Therapeutics Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline COPD Therapeutics Introduction
11.1.4 GlaxoSmithKline Revenue in COPD Therapeutics Business (2019-2024)
11.1.5 GlaxoSmithKline Recent Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca COPD Therapeutics Introduction
11.2.4 AstraZeneca Revenue in COPD Therapeutics Business (2019-2024)
11.2.5 AstraZeneca Recent Developments
11.3 Theravance Biopharma
11.3.1 Theravance Biopharma Company Details
11.3.2 Theravance Biopharma Business Overview
11.3.3 Theravance Biopharma COPD Therapeutics Introduction
11.3.4 Theravance Biopharma Revenue in COPD Therapeutics Business (2019-2024)
11.3.5 Theravance Biopharma Recent Developments
11.4 Mylan
11.4.1 Mylan Company Details
11.4.2 Mylan Business Overview
11.4.3 Mylan COPD Therapeutics Introduction
11.4.4 Mylan Revenue in COPD Therapeutics Business (2019-2024)
11.4.5 Mylan Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global COPD Therapeutics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of Bronchodilators
Table 3. Key Players of Inhaled Corticosteroids
Table 4. Key Players of Other
Table 5. Global COPD Therapeutics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 6. Global COPD Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global COPD Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global COPD Therapeutics Market Share by Region (2019-2024)
Table 9. Global COPD Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global COPD Therapeutics Market Share by Region (2025-2030)
Table 11. COPD Therapeutics Market Trends
Table 12. COPD Therapeutics Market Drivers
Table 13. COPD Therapeutics Market Challenges
Table 14. COPD Therapeutics Market Restraints
Table 15. Global COPD Therapeutics Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global COPD Therapeutics Revenue Share by Players (2019-2024)
Table 17. Global Top COPD Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COPD Therapeutics as of 2023)
Table 18. Global COPD Therapeutics Industry Ranking 2022 VS 2023 VS 2024
Table 19. Global 5 Largest Players Market Share by COPD Therapeutics Revenue (CR5 and HHI) & (2019-2024)
Table 20. Global Key Players of COPD Therapeutics, Headquarters and Area Served
Table 21. Global Key Players of COPD Therapeutics, Product and Application
Table 22. Global Key Players of COPD Therapeutics, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global COPD Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global COPD Therapeutics Revenue Market Share by Type (2019-2024)
Table 26. Global COPD Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global COPD Therapeutics Revenue Market Share by Type (2025-2030)
Table 28. Global COPD Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global COPD Therapeutics Revenue Share by Application (2019-2024)
Table 30. Global COPD Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global COPD Therapeutics Revenue Share by Application (2025-2030)
Table 32. North America COPD Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 33. North America COPD Therapeutics Market Size by Type (2025-2030) & (US$ Million)
Table 34. North America COPD Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 35. North America COPD Therapeutics Market Size by Application (2025-2030) & (US$ Million)
Table 36. North America COPD Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. North America COPD Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 38. North America COPD Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 39. Europe COPD Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 40. Europe COPD Therapeutics Market Size by Type (2025-2030) & (US$ Million)
Table 41. Europe COPD Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 42. Europe COPD Therapeutics Market Size by Application (2025-2030) & (US$ Million)
Table 43. Europe COPD Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Europe COPD Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 45. Europe COPD Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 46. China COPD Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 47. China COPD Therapeutics Market Size by Type (2025-2030) & (US$ Million)
Table 48. China COPD Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 49. China COPD Therapeutics Market Size by Application (2025-2030) & (US$ Million)
Table 50. Asia COPD Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 51. Asia COPD Therapeutics Market Size by Type (2025-2030) & (US$ Million)
Table 52. Asia COPD Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 53. Asia COPD Therapeutics Market Size by Application (2025-2030) & (US$ Million)
Table 54. Asia COPD Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 55. Asia COPD Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 56. Asia COPD Therapeutics Market Size by Region (2025-2030) & (US$ Million)
Table 57. Middle East, Africa, and Latin America COPD Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 58. Middle East, Africa, and Latin America COPD Therapeutics Market Size by Type (2025-2030) & (US$ Million)
Table 59. Middle East, Africa, and Latin America COPD Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America COPD Therapeutics Market Size by Application (2025-2030) & (US$ Million)
Table 61. Middle East, Africa, and Latin America COPD Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 62. Middle East, Africa, and Latin America COPD Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America COPD Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 64. GlaxoSmithKline Company Details
Table 65. GlaxoSmithKline Business Overview
Table 66. GlaxoSmithKline COPD Therapeutics Product
Table 67. GlaxoSmithKline Revenue in COPD Therapeutics Business (2019-2024) & (US$ Million)
Table 68. GlaxoSmithKline Recent Developments
Table 69. AstraZeneca Company Details
Table 70. AstraZeneca Business Overview
Table 71. AstraZeneca COPD Therapeutics Product
Table 72. AstraZeneca Revenue in COPD Therapeutics Business (2019-2024) & (US$ Million)
Table 73. AstraZeneca Recent Developments
Table 74. Theravance Biopharma Company Details
Table 75. Theravance Biopharma Business Overview
Table 76. Theravance Biopharma COPD Therapeutics Product
Table 77. Theravance Biopharma Revenue in COPD Therapeutics Business (2019-2024) & (US$ Million)
Table 78. Theravance Biopharma Recent Developments
Table 79. Mylan Company Details
Table 80. Mylan Business Overview
Table 81. Mylan COPD Therapeutics Product
Table 82. Mylan Revenue in COPD Therapeutics Business (2019-2024) & (US$ Million)
Table 83. Mylan Recent Developments
Table 84. Research Programs/Design for This Report
Table 85. Key Data Information from Secondary Sources
Table 86. Key Data Information from Primary Sources
List of Figures
Figure 1. Global COPD Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global COPD Therapeutics Market Share by Type: 2023 VS 2030
Figure 3. Bronchodilators Features
Figure 4. Inhaled Corticosteroids Features
Figure 5. Other Features
Figure 6. Global COPD Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global COPD Therapeutics Market Share by Application: 2023 VS 2030
Figure 8. Adult Case Studies
Figure 9. Child Case Studies
Figure 10. COPD Therapeutics Report Years Considered
Figure 11. Global COPD Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global COPD Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global COPD Therapeutics Market Share by Region: 2023 VS 2030
Figure 14. Global COPD Therapeutics Market Share by Players in 2023
Figure 15. Global Top COPD Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COPD Therapeutics as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by COPD Therapeutics Revenue in 2023
Figure 17. North America COPD Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America COPD Therapeutics Market Share by Type (2019-2030)
Figure 19. North America COPD Therapeutics Market Share by Application (2019-2030)
Figure 20. North America COPD Therapeutics Market Share by Country (2019-2030)
Figure 21. United States COPD Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada COPD Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe COPD Therapeutics Market Size YoY (2019-2030) & (US$ Million)
Figure 24. Europe COPD Therapeutics Market Share by Type (2019-2030)
Figure 25. Europe COPD Therapeutics Market Share by Application (2019-2030)
Figure 26. Europe COPD Therapeutics Market Share by Country (2019-2030)
Figure 27. Germany COPD Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France COPD Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. COPD Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy COPD Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia COPD Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries COPD Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. China COPD Therapeutics Market Size YoY (2019-2030) & (US$ Million)
Figure 34. China COPD Therapeutics Market Share by Type (2019-2030)
Figure 35. China COPD Therapeutics Market Share by Application (2019-2030)
Figure 36. Asia COPD Therapeutics Market Size YoY (2019-2030) & (US$ Million)
Figure 37. Asia COPD Therapeutics Market Share by Type (2019-2030)
Figure 38. Asia COPD Therapeutics Market Share by Application (2019-2030)
Figure 39. Asia COPD Therapeutics Market Share by Region (2019-2030)
Figure 40. Japan COPD Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. South Korea COPD Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. China Taiwan COPD Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Southeast Asia COPD Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. India COPD Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Australia COPD Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America COPD Therapeutics Market Size YoY (2019-2030) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America COPD Therapeutics Market Share by Type (2019-2030)
Figure 48. Middle East, Africa, and Latin America COPD Therapeutics Market Share by Application (2019-2030)
Figure 49. Middle East, Africa, and Latin America COPD Therapeutics Market Share by Country (2019-2030)
Figure 50. Brazil COPD Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Mexico COPD Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. Turkey COPD Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia COPD Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. Israel COPD Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. GCC Countries COPD Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. GlaxoSmithKline Revenue Growth Rate in COPD Therapeutics Business (2019-2024)
Figure 57. AstraZeneca Revenue Growth Rate in COPD Therapeutics Business (2019-2024)
Figure 58. Theravance Biopharma Revenue Growth Rate in COPD Therapeutics Business (2019-2024)
Figure 59. Mylan Revenue Growth Rate in COPD Therapeutics Business (2019-2024)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global COPD Therapeutics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of Bronchodilators
Table 3. Key Players of Inhaled Corticosteroids
Table 4. Key Players of Other
Table 5. Global COPD Therapeutics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 6. Global COPD Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global COPD Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global COPD Therapeutics Market Share by Region (2019-2024)
Table 9. Global COPD Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global COPD Therapeutics Market Share by Region (2025-2030)
Table 11. COPD Therapeutics Market Trends
Table 12. COPD Therapeutics Market Drivers
Table 13. COPD Therapeutics Market Challenges
Table 14. COPD Therapeutics Market Restraints
Table 15. Global COPD Therapeutics Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global COPD Therapeutics Revenue Share by Players (2019-2024)
Table 17. Global Top COPD Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COPD Therapeutics as of 2023)
Table 18. Global COPD Therapeutics Industry Ranking 2022 VS 2023 VS 2024
Table 19. Global 5 Largest Players Market Share by COPD Therapeutics Revenue (CR5 and HHI) & (2019-2024)
Table 20. Global Key Players of COPD Therapeutics, Headquarters and Area Served
Table 21. Global Key Players of COPD Therapeutics, Product and Application
Table 22. Global Key Players of COPD Therapeutics, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global COPD Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global COPD Therapeutics Revenue Market Share by Type (2019-2024)
Table 26. Global COPD Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global COPD Therapeutics Revenue Market Share by Type (2025-2030)
Table 28. Global COPD Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global COPD Therapeutics Revenue Share by Application (2019-2024)
Table 30. Global COPD Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global COPD Therapeutics Revenue Share by Application (2025-2030)
Table 32. North America COPD Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 33. North America COPD Therapeutics Market Size by Type (2025-2030) & (US$ Million)
Table 34. North America COPD Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 35. North America COPD Therapeutics Market Size by Application (2025-2030) & (US$ Million)
Table 36. North America COPD Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. North America COPD Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 38. North America COPD Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 39. Europe COPD Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 40. Europe COPD Therapeutics Market Size by Type (2025-2030) & (US$ Million)
Table 41. Europe COPD Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 42. Europe COPD Therapeutics Market Size by Application (2025-2030) & (US$ Million)
Table 43. Europe COPD Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Europe COPD Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 45. Europe COPD Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 46. China COPD Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 47. China COPD Therapeutics Market Size by Type (2025-2030) & (US$ Million)
Table 48. China COPD Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 49. China COPD Therapeutics Market Size by Application (2025-2030) & (US$ Million)
Table 50. Asia COPD Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 51. Asia COPD Therapeutics Market Size by Type (2025-2030) & (US$ Million)
Table 52. Asia COPD Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 53. Asia COPD Therapeutics Market Size by Application (2025-2030) & (US$ Million)
Table 54. Asia COPD Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 55. Asia COPD Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 56. Asia COPD Therapeutics Market Size by Region (2025-2030) & (US$ Million)
Table 57. Middle East, Africa, and Latin America COPD Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 58. Middle East, Africa, and Latin America COPD Therapeutics Market Size by Type (2025-2030) & (US$ Million)
Table 59. Middle East, Africa, and Latin America COPD Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America COPD Therapeutics Market Size by Application (2025-2030) & (US$ Million)
Table 61. Middle East, Africa, and Latin America COPD Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 62. Middle East, Africa, and Latin America COPD Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America COPD Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 64. GlaxoSmithKline Company Details
Table 65. GlaxoSmithKline Business Overview
Table 66. GlaxoSmithKline COPD Therapeutics Product
Table 67. GlaxoSmithKline Revenue in COPD Therapeutics Business (2019-2024) & (US$ Million)
Table 68. GlaxoSmithKline Recent Developments
Table 69. AstraZeneca Company Details
Table 70. AstraZeneca Business Overview
Table 71. AstraZeneca COPD Therapeutics Product
Table 72. AstraZeneca Revenue in COPD Therapeutics Business (2019-2024) & (US$ Million)
Table 73. AstraZeneca Recent Developments
Table 74. Theravance Biopharma Company Details
Table 75. Theravance Biopharma Business Overview
Table 76. Theravance Biopharma COPD Therapeutics Product
Table 77. Theravance Biopharma Revenue in COPD Therapeutics Business (2019-2024) & (US$ Million)
Table 78. Theravance Biopharma Recent Developments
Table 79. Mylan Company Details
Table 80. Mylan Business Overview
Table 81. Mylan COPD Therapeutics Product
Table 82. Mylan Revenue in COPD Therapeutics Business (2019-2024) & (US$ Million)
Table 83. Mylan Recent Developments
Table 84. Research Programs/Design for This Report
Table 85. Key Data Information from Secondary Sources
Table 86. Key Data Information from Primary Sources
List of Figures
Figure 1. Global COPD Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global COPD Therapeutics Market Share by Type: 2023 VS 2030
Figure 3. Bronchodilators Features
Figure 4. Inhaled Corticosteroids Features
Figure 5. Other Features
Figure 6. Global COPD Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global COPD Therapeutics Market Share by Application: 2023 VS 2030
Figure 8. Adult Case Studies
Figure 9. Child Case Studies
Figure 10. COPD Therapeutics Report Years Considered
Figure 11. Global COPD Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global COPD Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global COPD Therapeutics Market Share by Region: 2023 VS 2030
Figure 14. Global COPD Therapeutics Market Share by Players in 2023
Figure 15. Global Top COPD Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COPD Therapeutics as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by COPD Therapeutics Revenue in 2023
Figure 17. North America COPD Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America COPD Therapeutics Market Share by Type (2019-2030)
Figure 19. North America COPD Therapeutics Market Share by Application (2019-2030)
Figure 20. North America COPD Therapeutics Market Share by Country (2019-2030)
Figure 21. United States COPD Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada COPD Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe COPD Therapeutics Market Size YoY (2019-2030) & (US$ Million)
Figure 24. Europe COPD Therapeutics Market Share by Type (2019-2030)
Figure 25. Europe COPD Therapeutics Market Share by Application (2019-2030)
Figure 26. Europe COPD Therapeutics Market Share by Country (2019-2030)
Figure 27. Germany COPD Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France COPD Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. COPD Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy COPD Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia COPD Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries COPD Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. China COPD Therapeutics Market Size YoY (2019-2030) & (US$ Million)
Figure 34. China COPD Therapeutics Market Share by Type (2019-2030)
Figure 35. China COPD Therapeutics Market Share by Application (2019-2030)
Figure 36. Asia COPD Therapeutics Market Size YoY (2019-2030) & (US$ Million)
Figure 37. Asia COPD Therapeutics Market Share by Type (2019-2030)
Figure 38. Asia COPD Therapeutics Market Share by Application (2019-2030)
Figure 39. Asia COPD Therapeutics Market Share by Region (2019-2030)
Figure 40. Japan COPD Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. South Korea COPD Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. China Taiwan COPD Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Southeast Asia COPD Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. India COPD Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Australia COPD Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America COPD Therapeutics Market Size YoY (2019-2030) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America COPD Therapeutics Market Share by Type (2019-2030)
Figure 48. Middle East, Africa, and Latin America COPD Therapeutics Market Share by Application (2019-2030)
Figure 49. Middle East, Africa, and Latin America COPD Therapeutics Market Share by Country (2019-2030)
Figure 50. Brazil COPD Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Mexico COPD Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. Turkey COPD Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia COPD Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. Israel COPD Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. GCC Countries COPD Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. GlaxoSmithKline Revenue Growth Rate in COPD Therapeutics Business (2019-2024)
Figure 57. AstraZeneca Revenue Growth Rate in COPD Therapeutics Business (2019-2024)
Figure 58. Theravance Biopharma Revenue Growth Rate in COPD Therapeutics Business (2019-2024)
Figure 59. Mylan Revenue Growth Rate in COPD Therapeutics Business (2019-2024)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232